3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
6
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Central Nervous System Neoplasms
11
Breast Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
4
Sarcoma
4
Ovarian Neoplasms
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Gliosarcoma
3
Glioblastoma
3
Endometrial Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Brain Neoplasms
3
Astrocytoma
3
Uterine Cervical Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neuroblastoma
2
Kidney Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Carcinoma In Situ
2
Vomiting
1
Urinary Bladder Neoplasms
1
Tongue Neoplasms
1
Teratoma
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Sarcoma, Synovial
1
Sarcoma, Endometrial Stromal
1
Interventions
Paclitaxel
3
Docetaxel
3
Watchful Waiting
2
Tamoxifen
2
Immunohistochemistry
2
Goserelin
2
Everolimus
2
Cyclophosphamide
2
Bevacizumab
2
Anastrozole
2
vandetanib
1
pegfilgrastim
1
lonafarnib
1
exemestane
1
Trastuzumab
1
Sunitinib
1
Psychiatric Rehabilitation
1
Neoadjuvant Therapy
1
Metformin
1
Mental Status and Dementia Tests
1
Leuprolide
1
Letrozole
1
Lapatinib
1
High-Energy Shock Waves
1
Gene Expression Profiling
1
Doxorubicin
1
Dasatinib
1
Chemotherapy, Adjuvant
1
Biopsy, Needle
1
Amplified Fragment Length Polymorphism Analysis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Breast Neoplasms, Male
×
Chemotherapy, Adjuvant
×
Clear all
NCT00911716
2019-08-01
TC Avastin. ICORG 08-10, V6
Cancer Trials Ireland
Phase NA
Completed
106 enrolled